Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,447	1,228	16	33	154	131
Market Cap Growth	7847.47%	7498.61%	-50.63%	-78.71%	17.03%	258.20%
Enterprise Value	1,297	1,058	2	12	105	111
PE Ratio	-	-31.49	-0.67	-1.06	-6.24	-4.27
PB Ratio	10.09	7.79	1.56	1.84	3.37	8.78
P/FCF Ratio	-45.18	-49.22	-0.78	-1.18	-6.09	-7.55
P/OCF Ratio	-45.20	-49.22	-0.78	-1.18	-6.09	-7.56
EV/EBITDA Ratio	-24.92	-28.83	-0.08	-0.41	-4.67	-3.90
EV/EBIT Ratio	-23.83	-27.14	-0.07	-0.38	-4.24	-3.60
EV/FCF Ratio	-40.32	-42.43	-0.08	-0.43	-4.14	-6.37
Debt / Equity Ratio	0.00	0.00	0.01	0.03	0.00	0.02
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-0.02	-0.01	-0.01
Debt / FCF Ratio	-0.01	-0.02	-0.01	-0.02	-0.01	-0.02
Quick Ratio	11.11	14.75	2.00	2.66	5.71	4.18
Current Ratio	11.23	14.89	2.14	2.80	5.83	4.26
Return on Equity (ROE)	-61.80%	-79.70%	-133.10%	-120.00%	-61.90%	-182.90%
Return on Assets (ROA)	-46.90%	-52.90%	-69.80%	-67.30%	-39.80%	-88.00%
Return on Capital (ROIC)	-37.27%	-24.49%	-239.07%	-176.76%	-69.93%	-152.09%
Earnings Yield	-3.60%	-3.18%	-148.97%	-94.47%	-16.03%	-23.44%
FCF Yield	-2.13%	-2.03%	-128.71%	-84.94%	-16.42%	-13.25%
Buyback Yield / Dilution	-283.26%	-96.40%	-57.90%	-27.39%	-83.41%	-62.77%
Total Shareholder Return	-283.26%	-96.40%	-57.90%	-27.39%	-83.41%	-62.77%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).